bioLytical Laboratories Inc. Receives Health Canada Authorization for the iStatis COVID-19 Antigen Home Test
01 avr. 2022 20h00 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. announced today that it is launching a second test on its new platform, iStatis, after receiving Health Canada authorization for the iStatis COVID-19 Antigen Home Test for...
bioLytical Laboratories Inc. erhält CE-Kennzeichnung für iStatis COVID-19-Antigentest für den Heimgebrauch
21 mars 2022 08h31 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. hat heute bekanntgegeben, dass das Unternehmen eine neue Plattform, iStatis, auf den Markt bringt, und hat die CE-Kennzeichnung für den sofortigen Markteintritt in Europa...
bioLytical Laboratories Inc. reçoit son marquage CE pour le test antigénique à domicile de la COVID-19 iStatis
21 mars 2022 08h31 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. a annoncé aujourd'hui le lancement d'une nouvelle plateforme, iStatis, et a reçu son marquage CE pour l'entrée immédiate sur le marché européen de son test antigénique à...
bioLytical Laboratories Inc. Receives its CE Mark for the iStatis COVID-19 Antigen Home Test
21 mars 2022 05h00 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. announced today that it is launching a new platform, iStatis, and has received its CE Mark for immediate market entry into Europe for its iStatis COVID-19 Antigen Home...
bioLytical Laboratories Inc. Receives Health Canada Authorization for its iStatis COVID-19 Antigen Test
07 mars 2022 09h00 HE
|
bioLytical Laboratories Inc.
From the makers of INSTI®, bioLytical launches a new platform, iStatis, created to ensure every person in the world has access to reliable testingbioLytical has received Health Canada authorization to...
Health Canada Approves Canada’s First HIV Self Test
03 nov. 2020 06h00 HE
|
bioLytical Laboratories Inc.
VANCOUVER, British Columbia, Nov. 03, 2020 (GLOBE NEWSWIRE) -- For the first time, Canadians will have access to at-home HIV self test kits. bioLytical Laboratories, a world leader in rapid...
bioLytical Laboratories kündigt Markteinführung von 1-minütigem INSTI®-COVID-19-Antikörpertest an
16 oct. 2020 10h52 HE
|
bioLytical Laboratories Inc.
Neuer INSTI®-COVID-19-Antikörpertest von bioLytical erkennt in nur einer Minute SARS-CoV-2-spezifische Antikörper mit hoher GenauigkeitbioLytical erhält CE-Kennzeichnung und Zulassung für den Verkauf...
bioLytical Laboratories annonce le lancement d'INSTI®, un test de dépistage des anticorps à la COVID-19 avec des résultats disponibles en une minute
16 oct. 2020 10h52 HE
|
bioLytical Laboratories Inc.
Le test de dépistage des anticorps COVID-19 INSTI® en une minute est le nouveau test de bioLytical ; il détecte les anticorps au SARS-CoV-2 avec une grande précision.bioLytical a reçu le marquage CE...
bioLytical Laboratories Announces Launch of INSTI® 1-Minute COVID-19 Antibody Test
15 oct. 2020 10h46 HE
|
bioLytical Laboratories Inc.
INSTI® COVID-19 Antibody Test is bioLytical’s new one-minute test, detecting antibodies to SARS-CoV-2 with high accuracy.bioLytical has received CE Mark and approval to sell the test across Europe....
bioLytical Receives Funding to Develop 1-Minute COVID-19 Test
27 mai 2020 14h50 HE
|
bioLytical Laboratories Inc.
RICHMOND, British Columbia, May 27, 2020 (GLOBE NEWSWIRE) -- bioLytical Laboratories Inc, a world leader in rapid diagnostic tests for infectious diseases, is pleased to announce that it will...